{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:20:04Z","timestamp":1790518804647,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T00:00:00Z","timestamp":1607731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jmb.2020.166762","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T04:26:05Z","timestamp":1608179165000},"page":"166762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition"],"prefix":"10.1016","volume":"433","author":[{"given":"Joel D.","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshi","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddy L.","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Crispin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2020.166762_b0005","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2020.166762_b0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science."},{"key":"10.1016\/j.jmb.2020.166762_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2020.166762_b0020","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jmb.2020.166762_b0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.biochem.69.1.69","article-title":"Protein glucosylation and its role in protein folding","volume":"69","author":"Parodi","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jmb.2020.166762_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/S0969-2126(99)80095-1","article-title":"Glycoproteins: Glycan presentation and protein-fold stability","volume":"7","author":"Wormald","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2020.166762_b0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13361-017-1854-1","article-title":"Distinguishing sulfotyrosine containing peptides from their phosphotyrosine counterparts using mass spectrometry","volume":"29","author":"Chen","year":"2018","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.jmb.2020.166762_b0040","article-title":"The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication","author":"Clarke","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.jmb.2020.166762_b0045","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1021\/bi200346n","article-title":"The expanding horizons of asparagine-linked glycosylation","volume":"50","author":"Larkin","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmb.2020.166762_b0050","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2020.166762_b0055","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1021\/pr500414q","article-title":"Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: A requirement for stable antibody interactions","volume":"13","author":"Hayes","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jmb.2020.166762_b0060","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc\u03b3RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2020.166762_b0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ccell.2019.06.008","article-title":"Removal of N-linked glycosylation enhances PD-L1 detection and predicts anti-PD-1\/PD-L1 therapeutic efficacy","volume":"36","author":"Lee","year":"2019","journal-title":"Cancer Cell."},{"key":"10.1016\/j.jmb.2020.166762_b0070","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1073\/pnas.1813909116","article-title":"A glycan shield on chimpanzee CD4 protects against infection by primate lentiviruses (HIV\/SIV)","volume":"166","author":"Warren","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2020.166762_b0075","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.abc0870","article-title":"Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2","volume":"369","author":"Chan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmb.2020.166762_b0080","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.chom.2020.08.004","article-title":"Virus-receptor interactions of glycosylated SARS-CoV-2 spike and human ACE2 receptor","volume":"28","author":"Zhao","year":"2020","journal-title":"Cell Host Microbe."},{"issue":"07","key":"10.1016\/j.jmb.2020.166762_b0085","article-title":"Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike","volume":"2020","author":"Mehdipour","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2020.166762_b0090","doi-asserted-by":"crossref","DOI":"10.1021\/acscentsci.0c01056","article-title":"Beyond shielding: The roles of glycans in the SARS-CoV-2 spike protein","author":"Casalino","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jmb.2020.166762_b0095","article-title":"Comprehensive characterization of N- and O-glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2","author":"Shajahan","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.jmb.2020.166762_b0100","first-page":"1480","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"2019","author":"Watanabe","year":"1863","journal-title":"Biochim. Biophys. Acta \u2013 Gen. Subj."},{"key":"10.1016\/j.jmb.2020.166762_b0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/glycob\/cwy021","article-title":"Global aspects of viral glycosylation","volume":"28","author":"Bagdonaite","year":"2018","journal-title":"Glycobiology"},{"key":"10.1016\/j.jmb.2020.166762_b0110","doi-asserted-by":"crossref","first-page":"E8508","DOI":"10.1073\/pnas.1712592114","article-title":"Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jmb.2020.166762_b0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","article-title":"Structural basis for human coronavirus attachment to sialic acid receptors","volume":"26","author":"Alejandra Tortorici","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jmb.2020.166762_b0120","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.1809667116","article-title":"Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A","volume":"116","author":"Hulswit","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmb.2020.166762_b0125","doi-asserted-by":"crossref","DOI":"10.1021\/acscentsci.0c00855","article-title":"The SARS-COV-2 spike protein binds sialic acids and enables rapid detection in a lateral flow point of care diagnostic device","author":"Baker","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jmb.2020.166762_b0130","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3389\/fimmu.2020.01480","article-title":"Human sialome and coronavirus disease-2019 (COVID-19) pandemic: An understated correlation?","volume":"11","author":"Morniroli","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmb.2020.166762_b0135","doi-asserted-by":"crossref","first-page":"103436","DOI":"10.1016\/j.etap.2020.103436","article-title":"Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection","volume":"79","author":"Engin","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.jmb.2020.166762_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","author":"Clausen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2020.166762_b0145","article-title":"Effective inhibition of SARS-CoV-2 entry by heparin and enoxaparin derivatives","author":"Tandon","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2020.166762_b0150","article-title":"SARS-CoV-2 infection and transmission depends on heparan sulfates and is blocked by low molecular weight heparins","author":"Bermejo-Jambrina","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2020.166762_b0155","article-title":"Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin","author":"Mycroft-West","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2020.166762_b0160","doi-asserted-by":"crossref","first-page":"104873","DOI":"10.1016\/j.antiviral.2020.104873","article-title":"Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions","volume":"181","author":"Kim","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jmb.2020.166762_b0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in coronavirus glycan shields despite extensive glycosylation","volume":"11","author":"Watanabe","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmb.2020.166762_b0170","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.celrep.2018.07.080","article-title":"Site-specific glycosylation of virion-derived HIV-1 Env is mimicked by a soluble trimeric immunogen","volume":"24","author":"Struwe","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jmb.2020.166762_b0175","article-title":"Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike","author":"Derking","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2020.166762_b0180","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/bit.26904","article-title":"Impact of cell culture media additives on IgG glycosylation produced in Chinese hamster ovary cells","volume":"116","author":"Ehret","year":"2019","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jmb.2020.166762_b0185","article-title":"cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate","author":"Dey","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jmb.2020.166762_b0190","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jmb.2013.02.006","article-title":"Dissecting the molecular mechanism of IVIg therapy: The interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain","volume":"425","author":"Yu","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmb.2020.166762_b0195","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1074\/jbc.RA117.001207","article-title":"Restricted processing of CD16a\/Fc receptor IIIa N-glycans from primary human NK cells impacts structure and function","volume":"293","author":"Patel","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmb.2020.166762_b0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mam.2016.04.004","article-title":"Emerging roles of protein mannosylation in inflammation and infection","volume":"51","author":"Loke","year":"2016","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.jmb.2020.166762_b0205","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.str.2007.01.011","article-title":"Glycoprotein structural genomics: solving the glycosylation problem","volume":"15","author":"Chang","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2020.166762_b0215","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.str.2020.04.022","article-title":"Networks of HIV-1 envelope glycans maintain antibody epitopes in the face of glycan additions and deletions","volume":"28","author":"Seabright","year":"2020","journal-title":"Structure"},{"key":"10.1016\/j.jmb.2020.166762_b0220","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1084\/jem.20161160","article-title":"Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo","volume":"214","author":"Medina-Ram\u00edrez","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jmb.2020.166762_b0225","article-title":"In-silico evidence for two receptors based strategy of SARS-CoV-2","author":"Milanetti","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.jmb.2020.166762_b0230","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmb.2020.166762_b0235","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2020.1804241","article-title":"A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy","volume":"12","author":"Miao","year":"2020","journal-title":"MAbs"},{"key":"10.1016\/j.jmb.2020.166762_b0240","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/s41401-020-0430-6","article-title":"Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication","volume":"41","author":"Pang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jmb.2020.166762_b0245","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.jmb.2020.166762_b0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpb.2019.03.018","article-title":"N-glycans of complex glycosylated biopharmaceuticals and their impact on protein clearance","volume":"139","author":"Higel","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283620306872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283620306872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T21:38:30Z","timestamp":1758317910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283620306872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0022283620306872"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2020.166762","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2020.166762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"166762"}}